News coverage of The Economic Club of Washington, D.C.’s Signature Event on June 16, 2026, featuring Joaquin Duato, Chairman and Chief Executive Officer of Johnson & Johnson

Bloomberg: J&J Takes a Pass on Obesity Drugs to Focus Efforts on Cancer

Seeking Alpha: J&J avoiding GLP-1 space to focus on cancer drugs (JNJ:NYSE)

Investing.com: Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

GuruFocus: Johnson & Johnson (JNJ) Focuses on Cancer Drugs, Shuns GLP-1 Market

Bloomberg video: J&J is focused on fighting cancer, not obesity drugs, CEO says